James J. Marino is Director at Onconova Therapeutics, Inc. (ONTX). They have made 8 open-market trades across 2 companies since 2017, most recently 2024-11-18.
CIK 0001198578
8 open-market purchases totalling $171K since 2017, never a sale. Across 8 scored buys the stock is up 85.2% at ninety days, and 80.8 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 38% | 38% |
| Avg Move | +36.8% | +34.6% | +85.2% |
| Alpha | +37.1% | +32.6% | +80.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONTX | BUY | 2021-09-28 | 2021-09-28 | $4.20 | $25K | -8.2% | -10.8% | -29.7% |
| ONTX | BUY | 2021-02-16 | 2021-02-17 | $1.00 | $25K | -21.8% | -24.2% | -34.5% |
| ONTX | BUY | 2020-11-24 | 2020-11-27 | $0.26 | $10K | +22.8% | +72.5% | +423.1% |
| CLDX | BUY | 2020-06-09 | 2020-06-10 | $3.00 | $25K | +188.9% | +161.3% | +154.8% |
| ONTX | BUY | 2019-11-25 | 2019-11-26 | $0.20 | $30K | +155.1% | +136.5% | +290.1% |
| ONTX | BUY | 2019-09-25 | 2019-09-26 | $1.60 | $12K | -26.7% | -35.8% | -70.5% |
| CLDX | BUY | 2018-08-24 | 2018-08-28 | $0.48 | $19K | -14.0% | -9.2% | -39.8% |
| ONTX | BUY | 2017-04-26 | 2017-04-28 | $2.10 | $25K | -1.3% | -13.9% | -12.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.